Edition:
United States

Xenetic Biosciences Inc (XBIO.OQ)

XBIO.OQ on NASDAQ Stock Exchange Capital Market

3.69USD
20 Jul 2018
Change (% chg)

$-0.28 (-7.05%)
Prev Close
$3.97
Open
$3.97
Day's High
$3.97
Day's Low
$3.50
Volume
12,741
Avg. Vol
100,092
52-wk High
$8.94
52-wk Low
$1.45

Chart for

About

Xenetic Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on discovery, research and development of biologic drugs and novel oncology therapeutics. The Company’s lead investigational product candidate is oncology therapeutic XBIO-101, which is used for the treatment of progestin - resistant... (more)
No analyst recommendations are available for .

Overall

Beta: 0.91
Market Cap(Mil.): $34.61
Shares Outstanding(Mil.): 8.72
Dividend: --
Yield (%): --

Financials

  XBIO.OQ Industry Sector
P/E (TTM): -- 217.69 33.34
EPS (TTM): -0.29 -- --
ROI: -15.64 -3.65 13.18
ROE: -19.06 -5.62 15.09

Competitors

  Price Chg
Actelion Ltd (ATLN.S) -- --
Incyte Corporation (INCY.OQ) $69.20 -0.91

Earnings vs. Estimates